Varying effects of common tuberculosis drugs on enhancing clofazimine activity in vitro<subtitle>Effect of tuberculosis drugs on clofazimine activity</subtitle>
Emerging Microbes & Infections (2017) 6, e28; doi:http://10.1038/emi.2017.24; published online 26 April 2017
Main Authors: | Shuo Zhang, Wanliang Shi, Jie Feng, Wenhong Zhang, Ying Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-01-01
|
Series: | Emerging Microbes and Infections |
Online Access: | https://www.tandfonline.com/doi/10.1038/emi.2017.24 |
Similar Items
-
Clofazimine for the treatment of tuberculosis
by: Jacob A. M. Stadler, et al.
Published: (2023-02-01) -
Rv1453 is associated with clofazimine resistance in Mycobacterium tuberculosis
by: Lei Zhang, et al.
Published: (2023-10-01) -
Clofazimine: A journey of a drug
by: Jiabin Xu, et al.
Published: (2023-11-01) -
Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis
by: Sonnenkalb, L, et al.
Published: (2023) -
Identification of drug candidates that enhance pyrazinamide activity from a clinical compound library<subtitle>Clinical compounds that enhance pyrazinamide activity</subtitle>
by: Hongxia Niu, et al.
Published: (2017-01-01)